Related references
Note: Only part of the references are listed.Metabolic Profiling Associates with Disease Severity in Nonischemic Dilated Cardiomyopathy
Job A. J Verdonschot et al.
JOURNAL OF CARDIAC FAILURE (2020)
Re-balancing cellular energy substrate metabolism to mend the failing heart
Jan F. C. Glatz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Metabolomics in translational medicine - A link between acylcarnitines and atrial fibrillation
J. Krause et al.
CARDIOVASCULAR RESEARCH (2018)
Cardiovascular Metabolomics
Robert W. McGarrah et al.
CIRCULATION RESEARCH (2018)
Association of circulating metabolites with healthy diet and risk of cardiovascular disease: analysis of two cohort studies
Tasnime Akbaraly et al.
SCIENTIFIC REPORTS (2018)
Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
Sammy Elmariah et al.
JAMA CARDIOLOGY (2018)
Mitochondrial dysfunction in pathophysiology of heart failure
Bo Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Fatty acid oxidation disorders
J. Lawrence Merritt et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Potassium channels in the heart: structure, function and regulation
Eleonora Grandi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy
Andrea S. Pereyra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review
Miguel Ruiz-Canela et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients
David E. Lanfear et al.
JACC-HEART FAILURE (2017)
Plasma acylcarnitines are associated with pulmonary hypertension
Nancy Luo et al.
PULMONARY CIRCULATION (2017)
Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues
Marina Makrecka-Kuka et al.
SCIENTIFIC REPORTS (2017)
Metabolic Considerations in Atrial Fibrillation - Mechanistic Insights and Therapeutic Opportunities
Masahide Harada et al.
CIRCULATION JOURNAL (2017)
Computational models of atrial cellular electrophysiology and calcium handling, and their role in atrial fibrillation
Jordi Heijman et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure
Kenneth C. Bedi et al.
CIRCULATION (2016)
Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support
Tariq Ahmad et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Cardiac-Specific Down-Regulation of Carnitine Palmitoyltransferase-1b (CPT-1b) Prevents Cardiac Remodeling in Obese Mice
Yijie Zhang et al.
Obesity (2016)
Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure
Wynn G. Hunter et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Long-chain acylcarnitines activate cell stress and myokine release in C2C12 myotubes: calcium-dependent and -independent effects
Colin S. McCoin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2015)
Palmitoyl-carnitine increases RyR2 oxidation and sarcoplasmic reticulum Ca2+ leak in cardiomyocytes: Role of adenine nucleotide translocase
J. Roussel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models
Desiree Abdurrachim et al.
CARDIOVASCULAR RESEARCH (2015)
Chamber-specific changes in calcium-handling proteins in the type 2 diabetic human heart with preserved ejection fraction
Carol T. Bussey et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Metabolic Disturbances Identified in Plasma Are Associated With Outcomes in Patients With Heart Failure Diagnostic and Prognostic Value of Metabolomics
Mei-Ling Cheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Acylcarnitines-old actors auditioning for new roles in metabolic physiology
Colin S. McCoin et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
Beshay N. Zordoky et al.
PLOS ONE (2015)
Acylcarnitines activate proinflammatory signaling pathways
Jennifer M. Rutkowsky et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Metabolomics signature improves the prediction of cardiovascular events in elderly subjects
S. Rizza et al.
ATHEROSCLEROSIS (2014)
Energy Metabolic Reprogramming in the Hypertrophied and Early Stage Failing Heart A Multisystems Approach
Ling Lai et al.
CIRCULATION-HEART FAILURE (2014)
Inhibition of carnitine palymitoyltransferase1b induces cardiac hypertrophy and mortality in mice
K. R. Haynie et al.
DIABETES OBESITY & METABOLISM (2014)
Long-chain acylcarnitine content determines the pattern of energy metabolism in cardiac mitochondria
Marina Makrecka et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
CARDIAC POTASSIUM CHANNEL SUBTYPES: NEW ROLES IN REPOLARIZATION AND ARRHYTHMIA
Nicole Schmitt et al.
PHYSIOLOGICAL REVIEWS (2014)
Small and large animal models in cardiac contraction research: Advantages and disadvantages
Nima Milani-Nejad et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Serum Levels of Acylcarnitines Are Altered in Prediabetic Conditions
Manuel Mai et al.
PLOS ONE (2013)
A Plasma Long-Chain Acylcarnitine Predicts Cardiovascular Mortality in Incident Dialysis Patients
Sahir Kalim et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease
Svati H. Shah et al.
AMERICAN HEART JOURNAL (2012)
Carnitine Palmitoyltransferase-1b Deficiency Aggravates Pressure Overload-Induced Cardiac Hypertrophy Caused by Lipotoxicity
Lan He et al.
CIRCULATION (2012)
Carnitine and Acylcarnitines
Stephanie E. Reuter et al.
CLINICAL PHARMACOKINETICS (2012)
Postprandial changes in plasma acylcarnitine concentrations as markers of fatty acid flux in overweight and obesity
Maria A. Ramos-Roman et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Long-Chain Acylcarnitines Regulate the hERG Channel
Fabio Ferro et al.
PLOS ONE (2012)
Human Atrial Action Potential and Ca2+ Model Sinus Rhythm and Chronic Atrial Fibrillation
Eleonora Grandi et al.
CIRCULATION RESEARCH (2011)
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project
David M. S. McHugh et al.
GENETICS IN MEDICINE (2011)
Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events
Svati H. Shah et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Myocardial Fatty Acid Metabolism in Health and Disease
Gary D. Lopaschuk et al.
PHYSIOLOGICAL REVIEWS (2010)
Energy metabolism in heart failure and remodelling
Joanne S. Ingwall
CARDIOVASCULAR RESEARCH (2009)
Na+ Transport in Cardiac Myocytes; Implications for Excitation-contraction Coupling
Donald M. Bers et al.
IUBMB LIFE (2009)
Carnitine Insufficiency Caused by Aging and Overnutrition Compromises Mitochondrial Performance and Metabolic Control
Robert C. Noland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop
U. Spiekerkoetter et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Plasma Acylcarnitine Profiles Suggest Incomplete Long-Chain Fatty Acid β-Oxidation and Altered Tricarboxylic Acid Cycle Activity in Type 2 Diabetic African-American Women
Sean H. Adams et al.
JOURNAL OF NUTRITION (2009)
The Late Na+ Current (INa) Inhibitor Ranolazine Attenuates Effects of Palmitoyl-L-Carnitine to Increase Late INa and Cause Ventricular Diastolic Dysfunction
Yuzhi Wu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency
Paul J. Isackson et al.
MOLECULAR GENETICS AND METABOLISM (2008)
A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study
Christian J. F. Holubarsch et al.
CLINICAL SCIENCE (2007)
Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart
Nathalie Gaborit et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
The L-type calcium channel in the heart: the beat goes on
I Bodi et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Metabolic modulation with perhexiline in chronic heart failure - A randomized, controlled trial of short-term use of a novel treatment
L Lee et al.
CIRCULATION (2005)
Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease
SE Reuter et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2005)
Influence of pyruvate on contractile performance and Ca2+ cycling in isolated failing human myocardium
G Hasenfuss et al.
CIRCULATION (2002)
Effects of arrhythmogenic lipid metabolites on the L-type calcium current of diabetic vs. non-diabetic rat hearts
MT Ziolo et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Alteration of the membrane lipid environment by L-palmitoylcarnitine modulates KATP channels in guinea-pig ventricular myocytes
T Haruna et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2000)
Long-chain acylcarnitine induces Ca2+ efflux from the sarcoplasmic reticulum
KA Yamada et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
First clinical trial with etomoxir in patients with chronic congestive heart failure
S Schmidt-Schweda et al.
CLINICAL SCIENCE (2000)
Ranolazine attenuates palmitoyl-L-carnitine-induced mechanical and metabolic derangement in the isolated, perfused rat heart
K Maruyama et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Share Paper
